Unknown

Dataset Information

0

TMPRSS2, a novel host-directed drug target against SARS-CoV-2.

ABSTRACT:

SUBMITTER: Keller C 

PROVIDER: S-EPMC9308027 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells
| S-SCDT-EMBOJ-2021-107821 | biostudies-other
Unknown Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant.
| S-EPMC7836107 | biostudies-literature
Unknown Extracellular vimentin as a target against SARS-CoV-2 host cell invasion.
| S-EPMC7805437 | biostudies-literature
Unknown Host-directed editing of the SARS-CoV-2 genome.
| S-EPMC7643664 | biostudies-literature
Unknown Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
| S-EPMC7417922 | biostudies-literature
Unknown Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.
| S-EPMC7953435 | biostudies-literature
Unknown Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.
| S-EPMC8579950 | biostudies-literature
Unknown In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry.
| S-EPMC8573850 | biostudies-literature
Unknown Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
| S-EPMC8183009 | biostudies-literature
Unknown Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
| S-EPMC8513479 | biostudies-literature